MDXG - Latest News

MiMedx Group, Inc. (MDXG), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $683.6M. Trailing twelve-month P/E ratio is 111.14. Beta to the broader market is 1.42.

The article list below shows the most recent MDXG headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent MDXG Headlines

MIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026

globenewswire.com - Oct 14, 2026

MARIETTA, Ga. , Oct.

MiMedx Group, Inc (NASDAQ:MDXG) Receives Consensus Rating of “Moderate Buy” from Analysts

defenseworld.net - Oct 6, 2026

MiMedx Group, Inc (NASDAQ: MDXG - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seven analysts that are pres

Compugen (NASDAQ:CGEN) versus MiMedx Group (NASDAQ:MDXG) Head-To-Head Comparison

defenseworld.net - Sep 24, 2026

Compugen (NASDAQ: CGEN - Get Free Report) and MiMedx Group (NASDAQ: MDXG - Get Free Report) are both small-cap healthcare companies, but which is the

Protagonist Therapeutics (NASDAQ:PTGX) & MiMedx Group (NASDAQ:MDXG) Head-To-Head Review

defenseworld.net - Sep 24, 2026

MiMedx Group (NASDAQ: MDXG - Get Free Report) and Protagonist Therapeutics (NASDAQ: PTGX - Get Free Report) are both healthcare companies, but which i

MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter

globenewswire.com - Sep 23, 2026

Court Vacates FDA Determinations That AXIOFILL Is Not Minimally Manipulated and Should Be Classified as a Biological Product

How News Affects MDXG Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MDXG's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked MDXG news questions

What is the latest MDXG news headline?

The most recent MDXG headline (Oct 14, 2026) is "MIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the MDXG news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What MDXG news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual MDXG options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.